CNS/Neurology Market Research Reports & Industry Analysis
A neurologist is a medical doctor that specializes in the diagnosis, treatment and management of illnesses affecting the brain, spinal cord, and nervous system. Neurologists must complete at least three years of specialized training in neurology, after completing medical school. A neurosurgeon must go through much more extensive and rigorous schooling and training. On top of diagnosing and treating neurological disorders, neurosurgeons can also perform surgery on the brain, spinal cord, and nerves.
Pharmaceuticals in CNS/Neurology are one of leading fields in medicine in terms of funding and research. On top of growing patient numbers, there remains a comparatively high unmet need in treatment of many neurological diseases. With the potential of being one of the most lucrative therapy areas in the future pharmaceutical Industry, Alzheimer's disease offers the greatest commercial opportunity for pharmaceutical companies in neurology. Many of the therapeutic drugs used to treat CNS/Neurological disorders have lost their patent protection or market exclusivity, leading to greater research and market opportunities for competing pharmaceutical and medical device companies. Despite the widespread use of CNS drugs, knowledge of these agents is limited due to the anatomic and neurochemical complexity of the brain and spinal cord.
CNS/Neurology Industry Research & Market Reports
-
Glioma - Pipeline Insight, 2025
... covers the therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Geography Covered Global coverage Glioma: Understanding Glioma: Overview Glioma is a ... Read More
-
2025 Global Deep Brain Stimulation In Parkinson'S Disease Market Industry (2031 Outlook)
... market size data for a three-year historical trend (2019-2022), a three-year forecast estimate trends (2023-2025), and a five-year outlook projection (2026-2031) for 46 countries. The report also features written analysis on market definitions, market segments, ... Read More
-
Headache Disorders Global Market Report 2025
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Lewy Body Dementia Treatment Global Market Report 2025
... dementia treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly ... Read More
-
Oral Thin Films Market, By Product (Sublingual Film and Fast Dissolving Dental/Buccal Film), By Disease Indication (Schizophrenia, Migraine, Opioid Dependence, Nausea & Vomiting, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... bypassing the gastrointestinal tract and liver. This results in the faster absorption of the drug, greater bioavailability, and quick onset of action. Oral thin films are very convenient and easy to administer, without the need ... Read More
-
Gene Therapy Market by Type (Gene silencing), Vector (Viral (Retroviral, AAV), Non-viral (Oligonucleotide)), Gene Type (Receptors, Cytokine), Therapeutic Area (Oncology, Neurology), Delivery Method (In-Vivo, Ex-Vivo), RoA (IV) - Global Forecast to 2032
... of the gene therapy market has been significantly driven by increasing R&D investment by key players for the development gene therapy drugs and growing approval of novel gene therapies. However, complex regulatory frameworks and ethical ... Read More
-
Addiction Treatment Market, By Type (Alcohol Addiction, Tobacco/Nicotine Addiction, Opioid Addiction, and Others), By Drug Type (Opioids (Buprenorphine, Methadone, Naltrexone), Nicotine Replacement Therapies (Nicotine Gums, Nicotine Patches, Nicotine Lozenges, Non-Nicotine Medication, Varenicline, and Bupropion), By Distribution Channel (Hospital Pharmacies, Medical Stores, and Others), By Geography (North America, Latin America, Asia Pacific, Europe, Middle East, and Africa)
... that affects millions globally. It impacts individuals physically as well as emotionally and economically. The complexity of addiction demands professional treatment approaches to facilitate recovery. The addiction treatment market encompasses a wide range of services ... Read More
-
Neurological Biomarkers Market, By Biomarker Type (Artificial Tears, Imaging Biomarkers, Metabolomics Biomarkers, Proteomic Biomarkers, Genomics Biomarkers), By Application (Alzheimers Disease, Parkinsons Disease, Multiple Sclerosis, Autism Spectrum Disorders, Others), By End User (Hospital Laboratories, Clinical Diagnostic Centers, Research Organizations, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... such as Alzheimer's disease, Parkinson's disease, multiple sclerosis and others can boost demand for reliable neurological biomarkers. Furthermore, growing focus on development of precision medicine and companion diagnostics for neurological conditions can drive the market ... Read More
-
Chronic Pain Market, By Drug Class (Opioids, Non-steroidal anti-inflammatory drugs (NSAIDS), Anticonvulsants, Antidepressants, and Others), By Indication (Neuropathic pain, Arthritis pain, Chronic back pain, Cancer pain, Migraine, Fibromyalgia, and Others), By Application (Musculoskeletal, Neuropathy, Oncology, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... neurological disorders and fibromyalgia among others. Sedentary lifestyles and rising chronic diseases can increase the prevalence of chronic pain globally. It negatively impacts quality of life by limiting mobility and daily functioning. Global chronic pain ... Read More
-
Carrier Screening Global Market Report 2025 Including: 1) By Type: Expanded Carrier Screening; Targeted Disease Carrier Screening 2) By Medical Condition: Pulmonary Conditions; Hematological Conditions; Neurological Conditions 3) By Technology: DNA Sequencing; Polymerase Chain Reaction; Microarrays 4) By End User: Hospitals; Reference Laboratories; Physician Offices And Clinics Covering: Invitae Corporation; BGI Genomics Co. Ltd.; Centogene NV; Eurofins Scientific SE; Fulgent Genetics Inc.
... is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond. Reasons to Purchase Gain a truly global perspective with the ... Read More
-
Global Cerebral Palsy Treatment Market - 2023-2030
... palsy treatment market is expected to exhibit a CAGR of 3.7% during the forecast period 2024-2031. The growing awareness about cerebral palsy is one of the major factors that would drive the cerebral palsy treatment ... Read More
-
Global Glioblastoma(GBM) Treatment Market - 2024-2031
... nerve cells. Glioblastoma can occur at any age but tends to occur more often in older adults. Treatments include radiation, chemotherapy and surgery. North America region accounted for the largest market share. Competitive rivalry intensifies ... Read More
-
Innovations and Growth Opportunities in Electroceuticals for Chronic Diseases
... to revolutionize the field, creating promising opportunities for technology developers in the electroceutical industry for product development. However, the innovations face significant challenges, including non-selectivity, invasiveness, open-loop, and risk of data breach. As a result, ... Read More
-
U.S. Tardive Dyskinesia Treatment Market - 2024 - 2031
... Tardive dyskinesia (TD) is a neurological disease noted by involuntary, repetitive movements. The disease often results from long-term use of certain medications, particularly antipsychotics, prescribed for psychiatric conditions like schizophrenia and bipolar disorder. Symptoms include ... Read More
-
Neurology Market: A BCC Research Overview
... a thorough examination of the market’s drivers, constraints, and pipeline medications, as well as the competitive landscape, laws, epidemiology of neurological disorders, mergers and acquisitions. Market forecasts through 2029 are also covered in the report. ... Read More
-
Magnetic Resonance Imaging (MRI) Market by Product Type (Open MRI and Close MRI), by Field Strength (High Field System, Medium Field System and Low Field System), by Application (Brain and Neurological, Spine and Musculoskeletal, Vascular, Abdominal, Cardiac, Breast, and Others), and by Enduser (Hospitals, Imaging Centers, Ambulatory Surgical Centers, and Others) - Global Opportunity Analysis and Industry Forecast, 2025 – 2030
... improving healthcare facilities have increased the demand for better diagnosis and treatment, which in turn has been driving the magnetic resonance imaging market growth. Also, the rise in various cardiovascular, neurological, and ophthalmic diseases along ... Read More
-
2025 Diseases of the Nervous System Global Market Size & Growth Report with Updated Analysis & Forecasts
... 22 subregions, and 195 countries. Figures are from 2013 through 2024, with forecasts for 2025 and the next 5 years. The historical data utilizes in-depth survey results from companies selling diseases of the nervous system ... Read More
-
Remote Patient Monitoring (RPM) Market by Offering (Software, integrated device), Device (Wearable, implants, handheld), Function (Cardiac, Glucose, Multiparameter), Application (Diabetes, Cardio, Neuro), End user, & Region - Global Forecast to 2030
... patient monitoring market: More individuals are getting hospital-acquired infections (HAIs) such as bloodstream infections, urinary tract infections, pneumonia, and infections caused by C. difficile. These infections have been associated with critical health complications and death ... Read More
-
Radiopharmaceuticals in Nuclear Medicine Market, By Product Type (Diagnostic Nuclear Medicine and Therapeutic Nuclear Medicine), By Application (Oncolog, Cardiology, Neurology, Endocrinology, Others), By End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Diagnostic Centers, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
... introduced into the body. Radiopharmaceuticals consist of radioactive isotopes bonded to bioactive pharmaceutical compounds like monoclonal antibodies to selectively target tissues, organs or cells. On interaction with gamma cameras during scans, these help physicians gain ... Read More
-
RNA Interference (RNAi) Drug Delivery Market Report by Application (Infectious Disease, Cardiology, Oncology, Neurology, Ophthalmology, Urology, Metabolic Disorders, and Others), Technology (Nanoparticle Drug Delivery, Pulmonary Drug Delivery, Nucleic Acid Drug Delivery, Aptamer Drug Delivery), and Region 2025-2033
... 17.75% during 2025-2033. Ribonucleic acid interference (RNAi) drug delivery refers to a therapeutic solution to monitor gene expression or mutations. RNAi drug delivery is usually administered through intravenous, intra-dermal and intraperitoneal injections and topical delivery ... Read More
-
Deep Brain Stimulation Market Report by Stimulation Type (Subthalamic DBS, Globus Pallidus DBS, Thalamic DBS, Pedunculopontine Nucleus DBS), Product (Single Channel Deep Brain Stimulator, Dual Channel Deep Brain Stimulator), Application (Parkinson's Disease (PD), Epilepsy, Dystonia, Obsessive Compulsive Disorder (OCD), and Others), End-User (Hospitals, Ambulatory Surgical Centers, Neurological Centers, and Others), and Region 2025-2033
... 2025-2033. The rising occurrence of various motor and neurological disorders among the masses, growing acceptance of minimally invasive (MI) surgical methods, and construction of hospitals, nursing homes, and clinics across the globe represent some of ... Read More
-
Pain Management Drugs Market Report by Drug Class (NSAIDs, Anesthetics, Anticonvulsants, Antimigraine Agents, Antidepressants, Opioids, and Others), Indication (Musculoskeletal Pain, Surgical and Trauma Pain, Cancer Pain, Neuropathic Pain, Migraine Pain, Obstetrical Pain, Fibromyalgia Pain, Burn Pain, Dental/Facial Pain, Pediatric Pain, and Others), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2025-2033
... 2025-2033. The market is experiencing robust growth driven by the increasing prevalence of chronic diseases, rapid advancements in pain management therapies, heightened awareness and education about pain management, the implementation of supportive government and regulatory ... Read More
-
Global Central Nervous System (CNS) Stimulant Drugs Market 2025-2029
... period. The report on the central nervous system (CNS) stimulant drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The ... Read More
-
Robotic-Assisted Neurosurgery System Market Size, Share, and Trends Analysis - Global - 2025-2031 - MedCore - Includes: Capital Equipment Market, Services and Maintenance Revenue Market
... into: Capital Equipment Services & Maintenance Revenue Market Insights & Data Coverage Unit Sales & Average Selling Prices Market Size & Growth Trends Procedure Numbers Market Drivers & Limiters Market Forecasts Until 2031 Historical Data ... Read More
-
Neurosurgery Navigation Systems Market Size, Share, & Trend Analysis - Global - 2025-2031 - MedCore - Includes: Capital Equipment, and 2 more
... segments: Capital equipment Disposables & other accessories Service & maintenance revenue Market insights & data coverage Unit sales & average selling prices Market size & growth trends Procedure numbers Market drivers & limiters Market forecasts ... Read More